The amount of weight loss experienced on a GLP-1 medication differs greatly among people
Singh AK, Unnikrishnan AG, Zargar AH, et al
GLP-1s may additionally impact other physiological changes observed in the perimenopausal period, including vasomotor symptoms like hot flashes and night sweats, declines in bone health, and unhealthy changes in body composition (gains in fat mass and declines in muscle mass), but whether these impacts are beneficial or harmful for women's health remains unknown
Scrambling, frying, or boiling some eggs for breakfast can lead to a day of more balanced blood sugar and digestion
adults who currently take GLP-1 medications for weight loss purposes has risen to 11% in 2026, up significantly from 3% in 2024
Similarly, in the von Frey test, mice injected with the intraplantar vehicle after CFA induction displayed prolonged mechanical allodynia, which was significantly reversed by a single intraplantar administration of 5 or 10 g of exendin 939 (Fig